Related Experiment Video
Updated: Jul 2, 2025
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
SOCS1 expression in cancer cells: potential roles in promoting antitumor immunity
Subburaj Ilangumaran1, Yirui Gui1, Akhil Shukla1
1Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada.
Abstract:
Suppressor of cytokine signaling 1 (SOCS1) is a potent regulator immune cell responses and a proven tumor suppressor. Inhibition of SOCS1 in T cells can boost antitumor immunity, whereas its loss in tumor cells increases tumor aggressivity. Investigations into the tumor suppression mechanisms so far focused on tumor cell-intrinsic functions of SOCS1. However, it is possible that SOCS1 expression in tumor cells also regulate antitumor immune responses in a cell-extrinsic manner via direct and indirect mechanisms. Here, we discuss the evidence supporting the latter, and its implications for antitumor immunity.
Insights
Suppressor of cytokine signaling 1 (SOCS1) acts as a tumor suppressor by regulating immune responses. This review explores how SOCS1 in tumor cells influences antitumor immunity through extrinsic mechanisms, impacting cancer progression.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Suppressor of cytokine signaling 1 (SOCS1) is a key regulator of immune cell responses and a known tumor suppressor.
- SOCS1 loss in tumor cells enhances tumor aggressiveness, while its inhibition in T cells boosts antitumor immunity.
- Current research primarily focuses on SOCS1's intrinsic functions within tumor cells for tumor suppression.
Purpose of the Study:
- To review evidence for SOCS1's cell-extrinsic regulation of antitumor immune responses.
- To discuss the direct and indirect mechanisms by which tumor cell SOCS1 influences the immune system.
- To explore the implications of these findings for cancer immunotherapy.
Main Methods:
- Literature review and synthesis of existing research on SOCS1.
- Analysis of studies investigating SOCS1's role in both tumor cells and immune cells.
- Discussion of proposed direct and indirect mechanisms of SOCS1 action.
Main Results:
- Evidence suggests SOCS1 expressed in tumor cells can modulate antitumor immunity via extrinsic pathways.
- SOCS1 may directly or indirectly impact immune cell function and the tumor microenvironment.
- Understanding these extrinsic roles is crucial for developing effective cancer therapies.
Conclusions:
- SOCS1's function extends beyond tumor cell-intrinsic effects, significantly influencing antitumor immunity.
- Targeting SOCS1 in tumor cells could offer novel strategies to enhance immune-mediated cancer control.
- Further research into SOCS1's extrinsic mechanisms is warranted for advancing cancer treatment.
Related Concept Videos
01:27Tumor Immunotherapy
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:01Regulation of Hematopoietic Stem Cells
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...